1
![Dyax]()
![Dyax]()
![Dyax]()
Dyax
Leadership team
Henry E Blair (Founder)
Products/ Services
Biopharma, Biotechnology, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Cambridge, Massachusetts, United States
Established
1989
Company Registration
SEC CIK number: 0000907562
Traded as
NASDAQ:DYAX
URL
Overview
Location
Summary
Dyax Corp. is a publicly traded, biopharmaceutical company located in Burlington, Mass. It focuses on developing treatments for conditions related to the immune system and for hereditary angioedema (HAE). Founded in 1989 as Cambridge Biotech Corp., it changed its name in 2006 upon its merger with Dyax Inc.
History
Dyax's initial success came from the development of therapies to treat CAD (or Carbamylated Erythropoietin), a severe anemia. Dyax's medication, ReFactoR, was the first FDA-approved therapeutic for the condition and made the company's name an industry standard. In the mid-2000s, Dyax began to focus on HAE, and undertook a partnership with Genzyme Corporation which eventually led to the merger of the two companies in 2006.
Mission
Dyax is committed to discovering and developing innovative biotherapies that address unmet medical needs and improve the quality of life to patients with life-threatening and serious diseases.
Vision
Dyax's vision is to form enduring partnerships that drive the development of therapies to provide maximum benefit to patients.
Key Team
Henry E Blair (Founder)
Recognition and Awards
Dyax has received numerous awards and recognitions over the years including the 2009 Bio International Convention Annual Outstanding Partnering Award and the 2012 International Specialty Pharmaceutical New York Metro Entrepreneurs of the Year Award.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Henry E Blair (Founder)
Products/ Services
Biopharma, Biotechnology, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Cambridge, Massachusetts, United States
Established
1989
Company Registration
SEC CIK number: 0000907562
Traded as
NASDAQ:DYAX
URL